Environmental and Aerosolized SARS-CoV-2 Among Hospitalized COVID-19 Patients

Link to article at PubMed

J Infect Dis. 2020 Sep 9:jiaa575. doi: 10.1093/infdis/jiaa575. Online ahead of print.


During April and May 2020, we studied 20 hospitalized COVID-19 patients, their hospital rooms (fomites and aerosols), and their close contacts for molecular and culture evidence of SARS-CoV-2 virus. Among the more than 400 samples, we found molecular evidence of virus in most sample types, especially the nasopharygeal (NP), saliva, and fecal samples, but the prevalence of molecular positivity among fomites and aerosols was low. The agreement between NP swab and saliva positivity was high (89.5%, Kappa 0.79). Two NP swabs collected from patients on one and seven days post-symptom onset had evidence of infectious virus (2 passages over 14 days in Vero E6 cells). In summary, the low molecular prevalence and lack of viable SARS-CoV-2 virus in fomites and air samples implied low nosocomial risk SARS-CoV-2 transmission through inanimate objects or aerosols.

PMID:32905595 | DOI:10.1093/infdis/jiaa575

Leave a Reply

Your email address will not be published. Required fields are marked *